0.00Open0.01Pre Close0 Volume251 Open Interest840.00Strike Price0.00Turnover1793.97%IV9.16%PremiumJan 3, 2025Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.0018Delta0.0003Gamma76950.00Leverage Ratio-66.9497Theta0.0000Rho139.40Eff Leverage0.0001Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
No comment yet